"Designing Growth Strategies is in our DNA"

Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI100630

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence/ Incidence, by Cancer Type, by Key Regional/ Countries
    2. New Product Launches, by Key Market Players
    3. Pipeline Analysis, Cancer Biomarkers
    4. Key industry Developments - Mergers, Acquisitions and Partnerships
  5. Global Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.S.
      2. Canada
  7. Europe Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Others
    3. Market Analysis, Insights and Forecast – By Biomarker Type
      1. PSA
      2. HER-2
      3. EGFR
      4. KRAS
      5. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. Diagnostics & Research Laboratories
      3. Hospitals & Specialty Clinics
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Abbott
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. CENTOGENE N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. CENTOGENE N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Axon Medchem
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Sino Biological Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. R&D System
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. BioVision Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Myriad RBM
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendation
Read Less

Figure 1:  Global Cancer Biomarkers Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Cancer Biomarkers Market Value Share (%), by Cancer Cancer Type, 2018 & 2026

Figure 3:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Lung Cancer, 2015-2026

Figure 4:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Breast Cancer, 2015-2026

Figure 5:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Colorectal Cancer, 2015-2026

Figure 6:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Prostate Cancer, 2015-2026

Figure 7:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8:  Global Cancer Biomarkers Market Value Share (%), by Biomarker Type 2018 & 2026

Figure 9:  Global Cancer Biomarkers Market Forecast (US$ Mn), by PSA, 2015-2026

Figure 10:  Global Cancer Biomarkers Market Forecast (US$ Mn), by HER-2, 2015-2026

Figure 11:  Global Cancer Biomarkers Market Forecast (US$ Mn), by EGFR, 2015-2026

Figure 12:  Global Cancer Biomarkers Market Forecast (US$ Mn), by KRAS 2015-2026

Figure 13:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Others, 2015-2026

Figure 14:  Global Cancer Biomarkers Market Value Share (%), by End User, 2018 & 2026

Figure 15:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2015-2026

Figure 16:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Lung Cancer & Research Laboratories, 2015-2026

Figure 17:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Hospitals & Speciality Clinics, 2015-2026

Figure 18:  Global Cancer Biomarkers Market Forecast (US$ Mn), by Others, 2015-2026

Figure 19:  Global Cancer Biomarkers Market Value (US$ Mn), by Region, 2018 & 2026

Figure 20:  North America Cancer Biomarkers Market Value (US$ Mn), by Cancer Cancer Type, 2018 & 2026

Figure 21:  North America Cancer Biomarkers Market Value Share (%), by Cancer Cancer Type, 2018

Figure 22:  North America Cancer Biomarkers Market Value (US$ Mn), by Biomarker Type, 2018 & 2026

Figure 23:  North America Cancer Biomarkers Market Value Share (%), by Biomarker Type, 2018

Figure 24:  North America Cancer Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 25:  North America Cancer Biomarkers Market Value Share (%), by End User, 2018

Figure 26:  North America Cancer Biomarkers Market Value (US$ Mn), By Country, 2018 & 2026

Figure 27:  North America Cancer Biomarkers Market Value Share (%), By Country, 2018

Figure 28:  Europe Cancer Biomarkers Market Value (US$ Mn), by Cancer Cancer Type, 2018 & 2026

Figure 29:  Europe Cancer Biomarkers Market Value Share (%), by Cancer Cancer Type, 2018

Figure 30:  Europe Cancer Biomarkers Market Value (US$ Mn), by Biomarker Type, 2018 & 2026

Figure 31:  Europe Cancer Biomarkers Market Value Share (%), by Biomarker Type, 2018

Figure 32:  Europe Cancer Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 33:  Europe Cancer Biomarkers Market Value Share (%), by End User, 2018

Figure 34:  Europe Cancer Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 35:  Europe Cancer Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 36:  Asia Pacific Cancer Biomarkers Market Value (US$ Mn), by Cancer Type, 2018 & 2026

Figure 37:  Asia Pacific Cancer Biomarkers Market Value Share (%), by Cancer Type, 2018

Figure 38:  Asia Pacific Cancer Biomarkers Market Value (US$ Mn), by Biomarker Type, 2018 & 2026

Figure 39:  Asia Pacific Cancer Biomarkers Market Value Share (%), by Biomarker Type, 2018

Figure 40:  Asia Pacific Cancer Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 41:  Asia Pacific Cancer Biomarkers Market Value Share (%), by End User, 2018

Figure 42:  Asia Pacific Cancer Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 43:  Asia Pacific Cancer Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 44:  Latin America Cancer Biomarkers Market Value (US$ Mn), by Cancer Type, 2018 & 2026

Figure 45:  Latin America Cancer Biomarkers Market Value Share (%), by Cancer Type, 2018

Figure 46:  Latin America Cancer Biomarkers Market Value (US$ Mn), by Biomarker Type, 2018 & 2026

Figure 47:  Latin America Cancer Biomarkers Market Value Share (%), by Biomarker Type, 2018

Figure 48:  Latin America Cancer Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 49:  Latin America Cancer Biomarkers Market Value Share (%), by End User, 2018

Figure 50:  Latin America Cancer Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 51:  Latin America Cancer Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 52:  Middle East & Africa Cancer Biomarkers Market Value (US$ Mn), by Cancer Type, 2018 & 2026

Figure 53:  Middle East & Africa Cancer Biomarkers Market Value Share (%), by Cancer Type, 2018

Figure 54:  Middle East & Africa Cancer Biomarkers Market Value (US$ Mn), by Biomarker Type, 2018 & 2026

Figure 55:  Middle East & Africa Cancer Biomarkers Market Value Share (%), by Biomarker Type, 2018

Figure 56:  Middle East & Africa Cancer Biomarkers Market Value (US$ Mn), by End User, 2018 & 2026

Figure 57:  Middle East & Africa Cancer Biomarkers Market Value Share (%), by End User, 2018

Figure 58:  Middle East & Africa Cancer Biomarkers Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 59:  Middle East & Africa Cancer Biomarkers Market Value Share (%), By Country/ Sub-region, 2018

Figure 60:  Global Cancer Biomarkers Market Share (%), By Company, 2018

Table 1:  Global Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015–2026

Table 2:  Global Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015–2026

Table 3:  Global Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015–2026

Table 4:  Global Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015-2026

Table 6:  North America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015-2026

Table 7:  North America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 8:  North America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015-2026

Table 10:  Europe Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015-2026

Table 11:  Europe Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 12:  Europe Cancer Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015-2026

Table 14:  Asia Pacific Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015-2026

Table 15:  Asia Pacific Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 16:  Asia Pacific Cancer Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015-2026

Table 18:  Latin America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015-2026

Table 19:  Latin America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 20:  Latin America Cancer Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Cancer Type, 2015-2026

Table 22:  Middle East & Africa Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by Biomarker Type, 2015-2026

Table 23:  Middle East & Africa Cancer Biomarkers Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 24:  Middle East & Africa Cancer Biomarkers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 class=
  • Mar, 2020
  • 2018
  • 2015-2017
  • 125

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X